Jump to content

A bold, block-by-block readout of the NAD+ research — what the human precursor trials (NMN, NR) actually measured, why most oral products are precursors and not NAD+ itself, and where the IV-therapy evidence thins out.

NAD+ DOSAGE / STUDY AMOUNTS

Which NAD+ Dosage Amounts Were Studied?

Researchers tested several pill and drip amounts. No study has proved one right dose for you.

What an NAD+ dosage number tells you

No single NAD+ dose has been proved right for people. Most pill work centered on NMN and NR instead of plain NAD+. NMN can become NAD+, while NR comes from a vitamin and becomes NMN first. Daily amounts are shown in milligrams, and a milligram is one-thousandth of a gram.

Each number belongs to one study. It does not set your dose.

What pill and drip amounts people received

NMN trials tried several amounts. One gave women 250 mg/day [1]. Another used 300, 600, and 900 mg/day for 60 days. At 600 mg/day, the blood, walking, and safety findings looked best as a group [3]. A review covered amounts through 1200 mg [15], but did not call that amount safe or helpful.

One NR trial used 100, 300, and 1000 mg/day for 8 weeks [4]. A Parkinson’s disease study tried 3000 mg/day while checking safety. The source used here does not report whether that amount proved safe. A review covered 250-3000 mg [15]. Another study tested nicotinamide, one vitamin form, at 500 mg twice daily. It asked whether that might prevent skin cancer.

Published IV reports describe 250-1000 mg per visit over several hours, and one small study ran the drip for six hours. These figures describe experiments; none is your dose.

What pill and drip amounts people received

What happens to NAD+ after a pill or drip

IV NAD+ disappears from blood quickly. One small test watched from the moment a drip began. By about two hours, almost none was left. Much of the dose seemed to break apart outside cells. The whole NAD+ may never enter those cells.

NMN and NR pills act another way. Blood NAD+ stayed higher while people kept taking them [3][4]. After the pills stopped, readings moved back toward their starting point.

This quick blood loss helps explain why IV proof remains weak.

What pills, drips, shots, sprays, and patches change

Most good human research involved pills holding NMN, NR, or nicotinamide, one vitamin form [3][4]. Nicotinamide can become NAD+. Only a few small or old studies checked IV NAD+. Proof is thinner for shots into muscle or beneath skin. Nose sprays, under-the-tongue drops, and patches also lack good tests. Human skin studies did place nicotinamide on skin [13].

A 600 mg NMN pill [3] passes through the stomach. A vein drip holding 600 mg of NAD+ enters blood at once. The substances differ, as do their routes into blood. The pill must be digested before NMN becomes NAD+. Whole NAD+ starts in blood but leaves fast.

A number means little unless the form is named.

What heat, dampness, or dirty mixing can harm

NAD+ and NMN powders pull water from nearby air. They can grow damp, and heat can harm them. After a pharmacy mixes NAD+ for a shot, the liquid stays chilled and shielded from light. Some supplements get outside lab checks; others do not. A pill may not match its label.

One clear warning involved a pharmacy-mixed NAD+ injectable. Tests found a toxin made by bacteria, so the FDA placed it in Class I, the highest recall level. The product could cause serious harm.

The source used here does not state a brand name. Its warning concerns a tainted mixed injection. This site gives no product or dose advice.